Replies to post #188 on Klar-Voyant Bio Bros

[kklar1]

$PTLA $27.60 I exited this ticker here as it's just too close to it's catalyst for my comfort. An even trade, and freed up $$ for names with catalysts further out. PDUFA August 21 under priority review for BLA seeking FDA approval to reverse the blood thinning activity.